Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-173588
Filing Date
2025-08-05
Accepted
2025-08-05 16:53:37
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d905096d424b5.htm 424B5 369041
2 EX-FILING FEES d905096dexfilingfees.htm   iXBRL EX-FILING FEES 36633
3 GRAPHIC g905096g00g03.jpg GRAPHIC 52420
4 GRAPHIC g905096g01k21.jpg GRAPHIC 46576
  Complete submission text file 0001193125-25-173588.txt   657862

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT d905096dexfilingfees_htm.xml XML 5966
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282861 | Film No.: 251185803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)